The road to an FDA nod for Coherus BioSciences’ China-made PD-1 inhibitor has been long and tortuous. After a complete response letter and delayed preapproval inspections, the FDA found a fresh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback